13. Common Stock

In connection with the closing of the Company’s IPO, the Company filed an amended and restated certificate of incorporation and adopted amended and restated bylaws; and pursuant to the amended and restated certificate of incorporation, the Company is now authorized to issue 100,000,000 shares of common stock. The holders of each share of common stock are entitled to one vote per share held and are entitled to receive dividends, if and when declared by the Board, and to share ratably in the Company’s assets available for distribution to stockholders, in the event of liquidation.

The Company has reserved for future issuance the following shares of common stock related to the potential warrant exercise, future vesting of restricted stock, exercise of stock options, and the employee stock purchase plan:


	December 31, 2016
Common stock issuable under Bayer warrant		357,840
Options to purchase common stock		4,025,966
Restricted stock subject to future vesting		8,542
Employee Stock Purchase Plan		250,000

Total		4,642,348